Roivant Sciences Ltd (ROIV)
NASDAQ · Healthcare · Biotechnology
Roivant Sciences Ltd is a Healthcare company with a market capitalization of $26.62B.
5-Year Price History
Latest Annual Financials · FY ending March 31, 2026
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q4 2026 | May 20, 2026 | $-0.32 | $-0.35 | +8.6% |
| Q3 2026 | February 6, 2026 | $-0.24 | $-0.31 | +22.6% |
| Q2 2026 | November 10, 2025 | $-0.28 | $-0.30 | +6.7% |
| Q1 2026 | August 11, 2025 | $-0.25 | $-0.23 | -8.7% |
| Q4 2025 | May 29, 2025 | $-0.29 | $-0.26 | -10.3% |
| Q3 2025 | February 10, 2025 | $-0.20 | $-0.24 | +16.7% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 36,695,558 | 4.52% | 7.7 | +10.5% |
| June 30, 2026 | 33,212,917 | 4.09% | 4.3 | -0.1% |
| June 15, 2026 | 33,244,439 | 4.09% | 7.5 | -8.3% |
| May 29, 2026 | 36,233,835 | 4.46% | 4.1 | +32.4% |
| May 15, 2026 | 27,377,524 | 3.93% | 5.7 | +1.2% |
| April 30, 2026 | 27,055,375 | 3.88% | 4.8 | +10.6% |
| April 15, 2026 | 24,470,022 | 3.51% | 5.8 | -1.7% |
| March 31, 2026 | 24,884,496 | 3.57% | 4.3 | +6.4% |
Other Biotechnology Stocks
Frequently Asked Questions
What is Roivant Sciences Ltd's market cap?
As of August 13, 2026, Roivant Sciences Ltd (ROIV) has a market capitalization of $26.62B.
Does Roivant Sciences Ltd pay a dividend?
Roivant Sciences Ltd does not currently pay a dividend.
What sector is ROIV in?
Roivant Sciences Ltd is in the Healthcare sector, specifically the Biotechnology industry.
What is Roivant Sciences Ltd's short interest?
As of the July 15, 2026 FINRA settlement, 36,695,558 ROIV shares were sold short, or 4.52% of shares outstanding. Days to cover: 7.7. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Roivant Sciences Ltd's revenue?
In its latest reported fiscal year (ending March 31, 2026), Roivant Sciences Ltd reported revenue of $8.26M and net income of -$299.77M.
Ask your own questions about ROIV
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.